Reuters logo
Otonomy's ear infection drug succeeds in late-stage trial
January 5, 2017 / 12:19 PM / a year ago

Otonomy's ear infection drug succeeds in late-stage trial

Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the outer ear canal, met the main goal in a late-stage trial.

The drug, Otiprio, is approved for use in pediatric patients during tympanostomy tube placement surgery.

The company said it would submit a supplemental marketing approval application with the U.S. Food and Drug Administration in the first half of 2017. (Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below